TD Asset Management
IMMU

TD Asset Management’s Immunomedics Inc IMMU Stock Holding History

TD Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-131,045
Closed -$4.64M – 1423
2020
Q2 		$4.64M Buy
131,045
+32,920
+34% +$962K 0.01% 675
2020
Q1 		$1.32M Sell
98,125
-12,700
-11% -$214K ﹤0.01% 929
2019
Q4 		$2.35M Sell
110,825
-21,987
-17% -$388K ﹤0.01% 895
2019
Q3 		$1.76M Buy
132,812
+7,000
+6% +$103K ﹤0.01% 938
2019
Q2 		$1.75M Sell
125,812
-84,406
-40% -$1.27M ﹤0.01% 936
2019
Q1 		$4.04M Sell
210,218
-94,070
-31% -$1.52M 0.01% 750
2018
Q4 		$4.34M Sell
304,288
-6,500
-2% -$129K 0.01% 704
2018
Q3 		$6.47M Buy
310,788
+95,700
+44% +$2.27M 0.01% 653
2018
Q2 		$5.09M Buy
215,088
+44,288
+26% +$890K 0.01% 694
2018
Q1 		$2.5M Buy
170,800
+12,200
+8% +$199K ﹤0.01% 843
2017
Q4 		$2.56M Buy
158,600
+4,000
+3% +$47.2K ﹤0.01% 834
2017
Q3 		$2.16M Buy
154,600
+4,200
+3% +$41.9K ﹤0.01% 852
2017
Q2 		$1.33M Buy
150,400
+18,200
+14% +$128K ﹤0.01% 975
2017
Q1 		$855K Buy
+132,200
New +$670K ﹤0.01% 1078

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

TD Asset Management's IMMU Position: Q3 2020 in Review

TD Asset Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 131,045 shares — an estimated $4.64M sold.

TD Asset Management first reported a position in IMMU in Q1 2017 and held it in 14 quarters. The position peaked at $6.47M in Q3 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • TD Asset Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • TD Asset Management sold 131,045 Immunomedics Inc shares in Q3 2020, an estimated $4.64M.
  • TD Asset Management first reported a position in Immunomedics Inc in Q1 2017 and held it in 14 quarters.
  • TD Asset Management's Immunomedics Inc position peaked at $6.47M in Q3 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.